The radiation oncology market can be segmented based on technology, therapy type, and end-user.
Under technology, one of the sub-segments is Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT).
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy (SRS/SBRT) is a highly precise radiation therapy method that delivers a high dose of radiation to a small and well-defined tumor area. It is widely used to treat tumors located in the brain, spine, and other areas of the body. SRS/SBRT offers several advantages such as shorter treatment duration, reduced side effects, and improved patient outcomes. The increasing adoption of SRS/SBRT for the treatment of both primary and metastatic tumors is driving the growth of this sub-segment in the radiation oncology market.
The radiation oncology market is highly competitive, with several key players driving the growth and development of the industry. Some of the prominent market players include Varian Medical Systems, Elekta AB, Accuray Incorporated, Ion Beam Applications SA, and ViewRay, Inc. These companies are focusing on strategic partnerships, mergers and acquisitions, and product innovations to strengthen their market position. Additionally, they are investing in research and development activities to introduce advanced and technologically advanced radiation therapy systems to cater to the increasing demand for effective cancer treatment options.